Chemo/Immunotherapy Data Increasingly Compelling with Additional Follow-Up (BMIC-009) - 102204

Spotlight
Video

Chemo/Immunotherapy Data Increasingly Compelling with Additional Follow-Up (BMIC-009)

BeaconMedIC has 56 videos Subscribe Here

Loading........
Description: Dr. Jack West assesses the merits of a combination of chemotherapy with pembrolizumab (Keytruda) based on the evolving efficacy data, especially the maturing results for overall survival, with longer follow-up of the KEYNOTE-021g trial.
Shared By : BeaconMedIC
Posted on : 09/25/17
Added : 11 months ago
Category : Immunotherapy